Funding: 
AG is supported by the Q.M. Gastmann Wichers Foundation, Netherlands Leprosy Relief Foundation (NLR) together with the Turing Foundation (ILEP#: 701.02.49), the Order of Malta-Grants-for-Leprosy-Research (MALTALEP), and the EDCTP through a project entitled AE-TBC under Grant Agreement N° IP_09_32040. AG and AvH are supported by the Heiser Program for Research in Leprosy in The New York Community Trust (P13-000392).
borderline lepromatous leprosy
erythema nodosum leprosum
cell-mediated immunity
phenolic glycolipid-I
tuberculoid leprosy
lepromatous leprosy
reversal reaction
leprosy spectrum
elimination
Type 1
Type 2
T2R
ENL
T1R
CMI
ROM
MDT
LL
BT
BL
BB
TT
MB
PB
BI
RR